ICN Pharmaceuticals, Inc.

                            Long-Term Incentive Plan








                                TABLE OF CONTENTS


I.    PURPOSE

II.   DEFINITIONS

III.  OPERATION OF THE PLAN

      III.    1   General Plan Description

      III.    2   Eligibility

      III.    3   Performance Periods and Partial Performance Periods

      III.    4   Calculation of Excess Market Value

      III.    5   Determination of Restricted Stock Awards

      III.    6   Vesting of Restricted Stock Awards

      III.    7   Dividends on Restricted Stock Awards

IV.   OTHER PLAN PROVISIONS

      IV.1    Change in Position

      IV.2    Termination of Employment

      IV.3    Effect of Change in Control

      IV.4    Employee Rights

      IV.5    Transfer of Award

      IV.6    Plan Administration

      IV.7    Plan Duration and Modification

      IV.8    Adjustments

      IV.9    Effect of Certain Transactions

      IV.10   Withholding Tax

      IV.11   Validity

      IV.12   Applicable Law

Exhibit 1:  Allocation of Restricted Stock Awards

Exhibit 2:  Graphical Example of Performance Periods

Exhibit 3:  ICN Total Shareholder Return Example Calculation

Exhibit 4:  Restricted Stock Award Example Calculation





                            ICN PHARMACEUTICALS, INC.
                            LONG-TERM INCENTIVE PLAN

                                       -9-


I.    PURPOSE

The purpose of the ICN Pharmaceuticals, Inc. Long-Term Incentive Plan is to:

               Focus   Participants   on  creating   sustained   superior  total
               shareholder return relative to other pharmaceutical companies,

               Encourage stock ownership among the top executive group,

               Encourage team orientation among the top executive group, and

               Offer the top executive group a competitive  long-term  incentive
               opportunity, commensurate with performance.

II.   DEFINITIONS

"Award" refers to any incentive amount earned under the Plan.

"Board of  Directors"  refers to the Board of Directors of ICN  Pharmaceuticals,
Inc.

"Cause" means the commission of an act of fraud or intentional misrepresentation
or an act of  embezzlement,  misappropriation  or  conversion  of  assets of the
Company, Parent or any Subsidiary.

"Change in  Capitalization"  means any  increase or  reduction  in the number of
Shares, or any change (including,  but not limited to, a change in value) in the
Shares,  or exchange of Shares for a different number or kind of shares or other
securities of the Company,  by reason of a  reclassification,  recapitalization,
merger, consolidation,  reorganization,  spin-of, split-up, issuance of warrants
or rights of  debentures,  stock  dividend,  stock split or reverse stock split,
cash dividend, property dividend,  combination or exchange of shares, repurchase
of shares, change in corporate structure or otherwise.

"Change in Control" shall mean the occurrence during the term of the Plan of:

          (i)  The "acquisition" by any "Person" (as the term person is used for
               purposes of Section 13(d) or 14(d) of the Securities Exchange Act
               of  1934,  as  amended  (the  "Exchange   Act"))  of  "Beneficial
               Ownership"  (within the meaning of Rule 13d-3  promulgated  under
               the  Exchange  Act)  of  any  securities  of  the  Company  which
               generally  entitles the holder  thereof the vote for the election
               of directors of the Company (the "Voting Securities") which, when
               added to the Voting Securities then "Beneficially  Owned" by such
               person, would result in such Person  "Beneficially  Owning" forty
               percent  (40%)  or  more  of the  combined  voting  power  of the
               Company's then outstanding Voting Securities;  provided, however,
               that for  purposes of this  paragraph  (i), a Person shall not be
               deemed to have made an acquisition  of Voting  Securities if such
               Person:  (a) acquires  Voting  Securities  as a result of a stock
               split,  stock dividend or other corporate restructuring in which
               all  stockholders  of the  class of such  Voting  Securities  are
               treated on a pro rata basis;  (b) acquires the Voting  Securities
               directly from the Company;  (c) becomes the  Beneficial  Owner of
               more than the permitted percentage of Voting Securities solely as
               a result of the  acquisition of Voting  Securities by the Company
               which, by reducing the number of Voting  Securities  outstanding,
               increases the proportional number of shares Beneficially Owned by
               such  Person;  (d) is the  Company  or any  corporation  or other
               Person of which a  majority  of its  voting  power or its  equity
               securities or equity  interest is owned directly or indirectly by
               the  Company  (a  "Controlled  Entity")  or (e)  acquires  Voting
               Securities in connection  with a  "Non-Control  Transaction"  (as
               defined in paragraph (iii) below); or

          (ii) The individuals  who, as of November 10, 1994, are members of the
               Board of Directors of the Company (the "Incumbent Board"),  cease
               for any reason to constitute at least  two-thirds of the Board of
               Directors of the Company;  provided,  however, that if either the
               election of any new  director or the  nomination  for election of
               any new director by the Company's  stockholders was approved by a
               vote of a least  two-thirds  of the  Incumbent  Board,  such  new
               director shall be considered as a member of the Incumbent  Board;
               provided further, however, that no individual shall be considered
               a member  of the  Incumbent  Board if such  individual  initially
               assumed  office as a result  of  either  an actual or  threatened
               "Election Contest" (as described in Rule 14a-11 promulgated under
               the Exchange Act) or other actual or threatened  solicitation  of
               proxies or  consents  by or on behalf of a Person  other than the
               Board of Directors (a "Proxy Contest") including by reason of any
               agreement  intended  to avoid or settle any  Election  Contest or
               Proxy Contest; or

          (iii)Shareholder  approval  of  :  (a)  A  merger,   consolidation  or
               reorganization  involving the Company (a "Business Combination"),
               unless

               (1)  the  stockholders  of the  Company,  immediately  before the
                    Business   Combination,    own,   directly   or   indirectly
                    immediately  following  the Business  Combination,  at least
                    fifty-one  percent (51%) of the combined voting power of the
                    outstanding  voting securities of the corporation  resulting
                    from the Business Combination (the" Surviving  Corporation")
                    in  substantially  the same proportion as their ownership of
                    the  Voting  Securities   immediately  before  the  Business
                    Combination, and

               (2)  the  individuals  who were  members of the  Incumbent  Board
                    immediately   prior  to  the   execution  of  the  agreement
                    providing for the Business Combination constitute at least a
                    majority  of the  members of the Board of  Directors  of the
                    Surviving Corporation, and

               (3)  no Person (other than the Company or any Controlled  Entity,
                    a trustee or other fiduciary holding securities under one or
                    more employee  benefit plans or  arrangements  (or any trust
                    forming  a part  thereof)  maintained  by the  Company,  the
                    Surviving  Corporation  or  any  Controlled  Entity,  or any
                    Person who,  immediately prior to the Business  Combination,
                    had  Beneficial  Ownership of forty percent (40%) or more of
                    the  then  outstanding  Voting  Securities)  has  Beneficial
                    Ownership  of forty  percent  (40%) or more of the  combined
                    voting power of the Surviving Corporation's then outstanding
                    voting   securities   (a   transaction   described  in  this
                    subparagraph  (a)  shall be  referred  to as a  "Non-Control
                    Transaction");

                    (b)  A complete  liquidation  or dissolution of the Company;
                         or

                    (c)  The sale or other  disposition of all or  substantially
                         all of the assets of the  Company to any Person  (other
                         than a transfer to a Controlled Entity).

Notwithstanding  the  foregoing,  (x) a Change in Control shall not be deemed to
occur solely because forty percent (40%) or more of the then outstanding  Voting
Securities is  Beneficially  Owned by (A) a trustee or other  fiduciary  holding
securities  under one or more  employee  benefit plans or  arrangements  (or any
trust forming a part thereof) maintained by the Company or any Controlled Entity
or (B) any  corporation  which,  immediately  prior to its  acquisition  of such
interest,  is owned directly or indirectly by the stockholders of the Company in
the same proportion as their ownership of stock in the Company immediately prior
to such acquisition; and (y) if a Participant's employment is terminated and the
Participant reasonably demonstrates that such termination (A) was at the request
of a third  party who has  indicated  an  intention  or taken  steps  reasonably
calculated to effect a Change in Control and who effectuates a Change in Control
or (B) otherwise occurred in connection with, or in anticipation of, a Change in
Control  which  actually  occurs,  then for all purposes  hereof,  the date of a
Change  in  Control  with  respect  to  the  Participant  shall  mean  the  date
immediately prior to the date of such termination of employment.

"Company" refers to ICN Pharmaceuticals, Inc.

"Company's Total Shareholder Return" refers to the compounded annual growth rate
of the  Company's  stock  price over the given  Performance  Period (or  Partial
Performance  Period)  assuming that all dividends  paid during such  Performance
Period (or Partial  Performance  Period) were reinvested in the Company's stock.
Ratable adjustments will be made to reflect any stock splits or stock dividends.
A detailed  description  of how to calculate  the  Company's  Total  Shareholder
Return is contained in Exhibit 1 herewith.

"Compensation  Committee"  refers to the Compensation  Committee of the Board of
Directors of ICN Pharmaceuticals, Inc.

"Disability"   means  a  physical  or  mental   infirmity   which   impairs  the
Participant's ability to perform substantially his or her duties for a period of
one hundred eighty (180) days during any three hundred sixty (360) day period.

"Excess  Market  Value"  refers to an increase in ICN Market  Capitalization  as
defined in Section III.4 herein.

"Market Capitalization" refers to the common shares outstanding of the Company's
stock on the start  date of each  Performance  Period  (or  Partial  Performance
Period)  multiplied  by the  closing  price of the  stock on the New York  Stock
Exchange  per share on the start date of each  Performance  Period  (or  Partial
Performance Period).

"Parent" means any corporation which is a parent corporation (within the meaning
of Section 424(e) of the Code) with respect to the Company.

"Participant"  refers to those employees of the Company  eligible to participate
in the Plan subject to Section III.2 herein.

"Plan" refers to the ICN  Pharmaceuticals,  Inc.  Long-Term  Incentive  Plan, as
described herein.

"Pro Rata  Award"  refers  to the  percentage  of days in the final  year of the
Performance Period (or Partial  Performance Period) during which the Participant
was employed by the Company  multiplied by the Award that the Participant  would
have received had the Participant been employed through such Performance  Period
(or Partial Performance Period).

"Pro Rata Award  Percentage"  refers to the  time-weighted  average of all Award
Percentages for each eligible  position held by the Participant  during any Plan
year.

"Restricted  Stock Agreement"  means the written  agreement by which an Award of
restricted stock is evidenced.

"S&P 500's Total Shareholder Return" refers to the compounded annual growth rate
of the  Standard  and Poor's 500  Composite  Index's  stock price over the given
Performance Period (or Partial  Performance  Period) assuming that all dividends
paid  during  such  Performance  Period (or  Partial  Performance  Period)  were
reinvested in the stock.

"Shares" means the common stock, par value $.01 per share, of the Company.

"Subsidiary" means any corporation which is a subsidiary corporation (within the
meaning of Section 424(g) of the Code) with respect to the Company.

"Vest"  refers  to the time  when  ownership  of the  restricted  stock  awarded
pursuant to the Plan becomes non-forfeitable by the Participant.

III.  OPERATION OF THE PLAN

III.1  General Plan Description

The  Plan was  adopted  by the  Board of  Directors  on April  25,  1996 and was
approved by the Company's  shareholders  on May 29, 1996.  The Plan provides the
opportunity to earn restricted stock Awards based on the Company's Excess Market
Value.

III.2  Eligibility

Senior  executives  of the Company  holding  the  positions  of Chief  Executive
Officer,  Executive Vice President,  Senior Vice President, and Regional Manager
are eligible to  participate  in the Plan. At the beginning of each  Performance
Period,  Participants  will be  assigned a  percentage  of Excess  Market  Value
("Award Percentage") as contained in Exhibit 2 herewith.

III.3  Performance Periods and Partial Performance Periods

Awards are determined based on the Company's performance over the previous three
years (the "Performance Period").  Each Performance Period will begin on January
28 and will end on January 27, three years later.

Notwithstanding  the above,  Awards earned for the periods  beginning on January
28, 1996 and ending on January  27,  1997 and  January  27,  1998 (the  "Partial
Performance  Periods")  will be based on the Excess Market Value  calculated for
such  periods.  A  diagram  outlining  the  Performance   Periods  (and  Partial
Performance Periods) is shown in Exhibit 2.

III.4  Calculation of Excess Market Value

Excess Market Value for each Performance Period (or Partial  Performance Period)
is defined as the Company's  Market  Capitalization  multiplied by the Company's
Total Shareholder  Return in excess of the S&P 500's Total  Shareholder  Return.
The Excess Market Value, expressed as a formula, is:

- --------------------------------------------------------------------------------
Company's|     |Company's     |     |Company's        |     | S&P 500's        |
Excess   | (=) |Market        | (X) |Total Shareholder| (-) | Total Shareholder|
Value    |     |Capitalization|     |Return           |     | Return           |
- --------------------------------------------------------------------------------

In the event that the S&P 500's  Total  Shareholder  Return is greater  than the
Company's  Total  Shareholder  Return for any  Performance  Period  (or  Partial
Performance Period), no Excess Market Value is created and therefore no Award is
earned for such period.

III.5  Determination of Restricted Stock Awards

At the beginning of each  Performance  Period (or Partial  Performance  Period),
Participants  will  be  assigned  an  Award  Percentage.  The  sum of all  Award
Percentages for each Performance Period (or Partial Performance Period) will not
be greater than 6% of Excess Market Value. Each  Participant's  Award value will
equal his Award Percentage multiplied by the Company's Excess Market Value.

The total number of shares of restricted  stock awarded to the Participant  will
equal the Award value divided by the closing Company stock price on the New York
Stock Exchange on the end date of the Performance Period (or Partial Performance
Period). An example of the calculation of a Participant's restricted stock Award
is illustrated in Exhibit 4. Upon determination of the total number of shares of
restricted stock to be awarded to the  Participant,  the terms of the restricted
stock Award shall be set forth in a Restricted Stock Agreement.

III.6  Vesting of Restricted Stock Awards

Restricted  stock  awarded  pursuant to the Plan will Vest 25% per year starting
one year from date of grant.

III.7  Dividends on Restricted Stock Awards

Any dividends  paid on unvested  restricted  stock Awards will be held in escrow
until such Awards Vest.

IV.      OTHER PLAN PROVISIONS

IV.1  Change in Position

In the event of a hire or promotion  to an eligible  position,  the  Participant
will be assigned an Award  Percentage  and will receive a Pro Rata Award for any
Performance Period (or Partial Performance Period) which is in its final year as
of the date of such hire or  promotion.  For all other  Performance  Periods (or
Partial Performance Periods), the Participant will receive an Award equal to his
full Award Percentage multiplied by the Excess Market Value for such Performance
Periods (or Partial Performance Periods).

In the event of a promotion/demotion  within eligible positions, the Participant
will receive an Award for any Performance Period (or Partial Performance Period)
which  is in its  final  year  as of the  date  of a  promotion/demotion  within
eligible  positions  equal to the Pro Rata Award  Percentage  multiplied  by the
Excess Market Value for such Performance Period (or Partial Performance Period).
For  all  other  Performance  Periods  (or  Partial  Performance  Periods),  the
Participant   will  receive  an  Award  equal  to  the  full  Award   Percentage
commensurate  with the new position  multiplied  by the Excess  Market Value for
such Performance Periods (or Partial Performance Periods).

In the event of a demotion  to an  ineligible  position,  the  Participant  will
receive a Pro Rata  Award for any  Performance  Period (or  Partial  Performance
Period)  which  is in its  final  year  as of the  date of  such  demotion.  The
Participant  will not  receive  any Award for any other  Performance  Period (or
Partial Performance Period).

IV.2  Termination of Employment

If employment of the Participant in the Plan is terminated as a result of death,
Disability,  normal  retirement or the  Participant is terminated by the Company
without Cause,  (i) the unvested  portion of any restricted stock awarded to the
Participant under the Plan will Vest immediately,  and (ii) the Participant will
be  entitled  to a Pro  Rata  Award  for  any  Performance  Period  (or  Partial
Performance  Period)  which  is  in  its  final  year  as of  the  Participant's
termination  date.  Such Award  will be paid and will fully Vest  within two (2)
months of the final day of the Performance  Period (January 27). The Participant
forfeits the opportunity to earn any Awards for any other Performance Period (or
Partial Performance Period).

If the Participant's  employment with the Company is terminated prior to the end
of any unfinished  Performance  Periods (or Partial  Performance Period) for any
reason other than death,  Disability,  normal  retirement or  termination of the
Participant  by the Company  without  Cause,  the  Participant  will forfeit the
opportunity  to earn an Award under the Plan for such  periods and will  forfeit
the unvested portion of any previous restricted stock Awards granted pursuant to
the Plan.

IV.3  Effect of Change in Control

In the  event of a Change  in  Control,  all  Performance  Periods  (or  Partial
Performance Periods), will be deemed to be fulfilled as of the Change in Control
date. The  restricted  stock Awards will be based on the Excess Market Value for
such Performance Period (or Partial  Performance Period) and, subject to Section
IV.9,  granted to  Participants.  All restricted stock Awards issued pursuant to
the Plan shall become fully vested as of the Change in Control  date,  including
those granted in connection with a Change in Control.

In the event that any Award made to  Participants  will subject  Participants to
the Excise Tax imposed by Section 4999 of the Internal  Revenue Code of 1986, as
amended,  the Participant  will be entitled to receive an additional  payment (a
"Gross Up  Payment").  The Gross Up Payment is an amount such that after payment
by the Participant of all taxes  (including the Excise Tax) imposed on the Gross
Up Payment,  the Participant  retains an amount of the Gross Up Payment equal to
the Excise Tax imposed on the Award.

IV.4  Employee Rights

No employee has a claim or right to be a Participant in the Plan, to continue as
a Participant,  or to be granted an Award under the Plan.  Participation  in the
Plan does not give the Participant the right to be retained in the employment of
the Company, nor does it imply or confer any other employment rights.

Nothing  contained  in the  Plan  will be  construed  to  create a  contract  of
employment  with any  Participant.  The Company  reserves the right to elect any
person to its offices and to remove  employees  in any manner and upon any basis
permitted by law.

IV.5  Transfer of Award

Unvested  restricted  stock issued  pursuant to the Plan is  non-assignable  and
non-transferable  other than by will or by the laws of descent and  distribution
or pursuant to a qualified domestic relations order.

IV.6  Plan Administration

The  Plan  is  administered  by  the  Compensation  Committee  of the  Board  of
Directors. Subject to the provisions of the Plan, the Compensation Committee has
full authority to implement and carry out the Plan, including but not limited to
the  following:  to  construe  and  interpret  the Plan  and to make  all  other
determinations  necessary or advisable for the  administration  of the Plan. The
Compensation Committee must also approve that the performance criteria have been
met before any restricted stock Award is paid out.

IV.7  Plan Duration and Modification

The Plan shall remain in effect until all restricted  stock granted  pursuant to
the Plan has fully Vested.  The Compensation  Committee may, five years from the
approval of the Plan,  amend,  alter,  suspend or discontinue the Plan as it may
deem  proper,  except that no such action shall impair the rights of any grantee
under the Plan without the consent of the grantee.

No  restricted  stock Awards will be granted under the Plan after ten years from
the approval of the Plan.  Restricted  stock Awards granted pursuant to the Plan
will continue to Vest based on continued employment.

IV.8  Adjustments

In the event of a Change in Capitalization, the Compensation Committee shall, in
its sole discretion, make equitable adjustment of the number and class of common
shares  of the  Company's  stock  or  other  stock or  securities  covered  by a
Restricted Stock Agreement.

IV.9  Effect of Certain Transactions

With respect to any restricted  stock Award, in the event of (i) the liquidation
or dissolution of the Company,  (ii) a merger or consolidation of the Company or
(iii) a Change in Control (a  "Transaction"),  the Plan and the restricted stock
Awards  issued  hereunder  shall  continue  in effect in  accordance  with their
respective  terms, and each Participant  shall be entitled to receive in respect
of  each  common  share  of the  Company's  stock  subject  to  any  outstanding
restricted  stock  Awards,  upon  vesting,  the same  number  and kind of stock,
securities,  cash, property, or other consideration that each holder of a common
share of the  Company's  stock was  entitled  to receive in the  Transaction  in
respect of a common share of the Company's stock.

IV.10  Withholding Tax

The  Participant  will  pay to  the  Company  a cash  amount  equal  to any  tax
withholding obligation of the Company arising by reason of: (1) the Award of the
restricted shares; or (2) the Vesting of the restricted shares.

IV.11  Validity

In the event any provision of the Plan is held invalid,  void, or unenforceable,
the same shall not affect, in any respect whatsoever,  the validity of any other
provision of the Plan.

IV.12  Applicable Law

The Plan will be governed by and  construed in  accordance  with the laws of the
State of California.